![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 31, 29216-29230, August 1, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B Activation*









||
From the
Institute of Cell Biology and Immunology,
University of Stuttgart, Allmandring 31, 70569 Stuttgart, Germany, the
Department of Physiological Chemistry,
University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, Germany, and the
¶Department of Vascular Biology and Thrombosis
Research, University of Vienna, 1235 Vienna, Austria
The role of tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1
in NF-
B activation by various members of the TNF receptor family is not
well understood, and conflicting data have been published. Here, we show that
TRAF1 differentially affects TRAF2 recruitment and activation of NF-
B
by members of the TNF receptor family. Interestingly, a naturally occurring
caspase-derived cleavage product of TRAF1 solely comprising its TRAF domain
(TRAF1-(164416)) acted as a general inhibitor of NF-
B
activation. In contrast, a corresponding fragment generated by cleavage of
TRAF3 showed no effect in this regard. In accordance with these functional
data, TRAF1, but not TRAF3, interacted with the IKK complex via its N-TRAF
domain. Endogenous TRAF1 and the overexpressed TRAF domain of TRAF1 were found
to be constitutively associated with the IKK complex, whereas endogenous
receptor interacting protein was only transiently associated with the IKK
complex upon TNF stimulation. Importantly, the caspase-generated
TRAF1-fragment, but not TRAF1 itself inhibited IKK activation. Our results
suggest that TRAF1 and TRAF1-(164416) exert their regulatory effects on
receptor-induced NF-
B activation not only by modulation of TRAF2
receptor interaction but especially TRAF1-(164416) also by directly
targeting the IKK complex.
Received for publication, October 30, 2002 , and in revised form, March 17, 2003.
* This work was supported by Deutsche Forschungsgemeinschaft Grants Wa 1025/3-1, SFB 495/A5, and SFB 497/B1. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|| To whom correspondence should be addressed: Dept. of Molecular Internal Medicine, Medical Polyclinic, University of Wuerzburg, Roentgenring 11, 97070 Wuerzburg, Germany. Tel.: 49-931-201-71000; Fax: 49-931-201-71070; E-mail: harald.wajant{at}mail.uni-wuerzburg.de.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Baumel, A. Lechner, T. Hehlgans, and D. N. Mannel Enhanced susceptibility to Con A-induced liver injury in mice transgenic for the intracellular isoform of human TNF receptor type 2 J. Leukoc. Biol., July 1, 2008; 84(1): 162 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sabbagh, G. Pulle, Y. Liu, E. N. Tsitsikov, and T. H. Watts ERK-Dependent Bim Modulation Downstream of the 4-1BB-TRAF1 Signaling Axis Is a Critical Mediator of CD8 T Cell Survival In Vivo J. Immunol., June 15, 2008; 180(12): 8093 - 8101. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Oyoshi, P. Bryce, S. Goya, M. Pichavant, D. T. Umetsu, H. C. Oettgen, and E. N. Tsitsikov TNF Receptor-Associated Factor 1 Expressed in Resident Lung Cells Is Required for the Development of Allergic Lung Inflammation J. Immunol., February 1, 2008; 180(3): 1878 - 1885. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sabbagh, C. C. Srokowski, G. Pulle, L. M. Snell, B. J. Sedgmen, Y. Liu, E. N. Tsitsikov, and T. H. Watts A critical role for TNF receptor-associated factor 1 and Bim down-regulation in CD8 memory T cell survival PNAS, December 5, 2006; 103(49): 18703 - 18708. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Xie, B. S. Hostager, M. E. Munroe, C. R. Moore, and G. A. Bishop Cooperation between TNF Receptor-Associated Factors 1 and 2 in CD40 Signaling J. Immunol., May 1, 2006; 176(9): 5388 - 5400. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Bryce, M. K. Oyoshi, S. Kawamoto, H. C. Oettgen, and E. N. Tsitsikov TRAF1 regulates Th2 differentiation, allergic inflammation and nuclear localization of the Th2 transcription factor, NIP45 Int. Immunol., January 1, 2006; 18(1): 101 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Y. Ma, S. A. Mikolajczak, A. Danesh, K. A. Hosiawa, C. M. Cameron, A. Takaori-Kondo, T. Uchiyama, D. J. Kelvin, and A. Ochi The expression and the regulatory role of OX40 and 4-1BB heterodimer in activated human T cells Blood, September 15, 2005; 106(6): 2002 - 2010. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Pryhuber, H. L. Huyck, J. M. Roper, J. Cornejo, M. A. O'Reilly, R. H. Pierce, and E. N. Tsitsikov Acute Tumor Necrosis Factor-{alpha}-Induced Liver Injury in the Absence of Tumor Necrosis Factor Receptor-Associated Factor 1 Gene Expression Am. J. Pathol., June 1, 2005; 166(6): 1637 - 1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fotin-Mleczek, F. Henkler, A. Hausser, H. Glauner, D. Samel, A. Graness, P. Scheurich, D. Mauri, and H. Wajant Tumor Necrosis Factor Receptor-associated Factor (TRAF) 1 Regulates CD40-induced TRAF2-mediated NF-{kappa}B Activation J. Biol. Chem., January 2, 2004; 279(1): 677 - 685. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |